Rob DiCicco
Rob DiCicco, Vice President of Portfolio Management at TransCelerate BioPharma, has spent his career working at the intersection of clinical research, technology and operations.
Articles by Rob DiCicco
| 4 min read
New regulatory frameworks, shifting incentives, and pragmatic trial designs could finally move patient engagement from rhetoric to reality.
| 4 min read
AI could transform clinical trials, but its impact depends on overcoming deep-rooted challenges in data sharing, trust, regulation, and collaboration.
Page 1 of 1 - 2 Total Items
